Hamel Associates’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.93M | Sell |
|
|||||
|
2025
Q1 | $4.58M | Buy |
|
|||||
|
2024
Q4 | $845K | Hold |
|
|||||
|
2024
Q3 | $998K | Buy |
|
|||||
|
2024
Q2 | $920K | Hold |
|
|||||
|
2024
Q1 | $836K | Sell |
|
|||||
|
2023
Q4 | $923K | Sell |
|
|||||
|
2023
Q3 | $982K | Hold |
|
|||||
|
2023
Q2 | $973K | Hold |
|
|||||
|
2023
Q1 | $887K | Sell |
|
|||||
|
2022
Q4 | $876K | Hold |
|
|||||
|
2022
Q3 | $734K | Hold |
|
|||||
|
2022
Q2 | $816K | Sell |
|
|||||
|
2022
Q1 | $921K | Sell |
|
|||||
|
2021
Q4 | $1.25M | Sell |
|
|||||
|
2021
Q3 | $3.35M | Sell |
|
|||||
|
2021
Q2 | $4.52M | Sell |
|
|||||
|
2021
Q1 | $4.32M | Sell |
|
|||||
|
2020
Q4 | $4.96M | Sell |
|
|||||
|
2020
Q3 | $4.62M | Buy |
|
|||||
|
2020
Q2 | $4.62M | Sell |
|
|||||
|
2020
Q1 | $4.39M | Buy |
|
|||||
|
2019
Q4 | $5.02M | Sell |
|
|||||
|
2019
Q3 | $4.66M | Sell |
|
|||||
|
2019
Q2 | $4.92M | Sell |
|
|||||
|
2019
Q1 | $5.22M | Buy |
|
|||||
|
2018
Q4 | $4.64M | Hold |
|
|||||
|
2018
Q3 | $4.66M | Buy |
|
|||||
|
2018
Q2 | $3.98M | Sell |
|
|||||
|
2018
Q1 | $4.28K | Sell |
|
|||||
|
2017
Q4 | $4.46M | Buy |
|
|||||
|
2017
Q3 | $4.56M | Sell |
|
|||||
|
2017
Q2 | $4.47M | Sell |
|
|||||
|
2017
Q1 | $4M | Buy |
|
|||||
|
2016
Q4 | $3.77M | Buy |
|
|||||
|
2016
Q3 | $4.08M | Hold |
|
|||||
|
2016
Q2 | $4.26M | Buy |
|
|||||
|
2016
Q1 | $3.33M | Buy |
|
|||||
|
2015
Q4 | $3.05M | Buy |
|
|||||
|
2015
Q3 | $2.96M | Sell |
|
|||||
|
2015
Q2 | $3.19M | Sell |
|
|||||
|
2015
Q1 | $3.32M | Sell |
|
|||||
|
2014
Q4 | $3.34M | Hold |
|
|||||
|
2014
Q3 | $3.4M | Sell |
|
|||||
|
2014
Q2 | $3.31M | Sell |
|
|||||
|
2014
Q1 | $3.12M | Sell |
|
|||||
|
2013
Q4 | $2.99M | Buy |
|